• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7213
Device Problem Break (1069)
Patient Problems Foreign Body In Patient (2687); Vascular Dissection (3160); Foreign Body Embolism (4439)
Event Date 05/16/2022
Event Type  Injury  
Event Description
It was reported via facility medwatch report (b)(4) that shaft break, vessel dissection, and embolism occurred.A heart catheterization was performed in work up for a transcatheter aortic valve replacement (tavr).A 3.00mm x 15mm nc emerge balloon catheter was advanced for dilation.However, when the balloon was backed out, the shaft of the balloon broke off "after the black tip, proximal part of the monorail" causing coronary artery dissection and embolization.Dissection was at 100% non-flowing and there was no snaring involved.The physician decided to leave the balloon in the vessel because the vessel was poor.The patient was monitored for 1.5 hours post procedure in the catheterization lab and then was moved to critical care for monitoring and overnight observation.An echocardiogram was performed to evaluate for left ejection friction and regional wall motion, no changes were noted.The patient was discharged the following day and will be anticipating tavr done in 1 month.
 
Manufacturer Narrative
E1: initial reporter title: risk manager.Device evaluated by mfr.: the complaint device was not received at the complaint investigation site for analysis.Photo media was provided for investigation review.Photos one and two show the end of a device, a batch number cannot be determined as the photo did not provide evidence of the lot number.No damage was depicted to the photo and is deemed not applicable.The photo tree shows one part and the end of a device, a batch number cannot be determined as the photo did not provide evidence of the lot number.No damage was depicted to the photo and is deemed not applicable.Photo four depicts a device that contains blood on the manifold and looks to be separated at the end of the shaft from the balloon.There also shows the lot number on the manifold 28906590 which matches the complaint batch, and therefore applies to this compliant.Photo five shows one part and the end of a device, a batch number cannot be determined as the photo did not provide evidence of the lot number.No damage was depicted to the photo and is deemed not applicable.
 
Event Description
It was reported via facility medwatch report (b)(4) that shaft break, vessel dissection, and embolism occurred.A heart catheterization was performed in work up for a transcatheter aortic valve replacement (tavr).A 3.00mm x 15mm nc emerge balloon catheter was advanced for dilation.However, when the balloon was backed out, the shaft of the balloon broke off "after the black tip, proximal part of the monorail" causing coronary artery dissection and embolization.Dissection was at 100% non-flowing and there was no snaring involved.The physician decided to leave the balloon in the vessel because the vessel was poor.The patient was monitored for 1.5 hours post procedure in the catheterization lab and then was moved to critical care for monitoring and overnight observation.An echocardiogram was performed to evaluate for left ejection friction and regional wall motion, no changes were noted.The patient was discharged the following day and will be anticipating tavr done in 1 month.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key14739238
MDR Text Key294394955
Report Number2134265-2022-06291
Device Sequence Number1
Product Code LOX
UDI-Device Identifier08714729846529
UDI-Public08714729846529
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K141236
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date 07/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/21/2024
Device Model Number7213
Device Catalogue Number7213
Device Lot Number0028906590
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/27/2022
Initial Date FDA Received06/17/2022
Supplement Dates Manufacturer Received06/30/2022
Supplement Dates FDA Received07/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/21/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other; Hospitalization;
Patient Age74 YR
Patient SexFemale
Patient Weight85 KG
-
-